PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

NCT00011778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: bortezomib
RADIATION: radiation therapy

Sponsor

National Cancer Institute (NCI)